Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

5.36
Delayed Data
As of May 27
 -0.08 / -1.47%
Today’s Change
4.21
Today|||52-Week Range
12.47
-25.56%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close5.44
Today’s open5.50
Day’s range5.29 - 5.50
Volume19,505
Average volume (3 months)67,116
Market cap$149.3M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)-0.38%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
TROVTrovagene Inc-0.04-0.75%
OXFDOxford Immunotec Glo...-0.20-2.18%
CALACalithera Bioscience...0.000.00%
TRILTrillium Therapeutic...-0.04-0.38%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs